Overview

DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)

Status:
Completed

Trial end date:
2014-05-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if there is an interaction in healthy subjects taking BMS-663068 with Darunavir/Ritonavir and/or Etravirine.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb
ViiV Healthcare

Collaborator:

GlaxoSmithKline

Treatments:

Darunavir
Etravirine
Fostemsavir
Ritonavir